人工智能在磁共振成像预测直肠癌患者淋巴结转移中的价值:一项Meta分析
该Meta分析纳入17项研究,评估基于MRI的人工智能术前检测直肠癌淋巴结转移的诊断效能,并与放射科医生比较。AI汇总敏感度0.71、特异度0.71、AUC 0.77,放射科医生分别为0.64、0.72、0.74,两者诊断性能相似;研究间高异质性限制证据强度,需外部验证数据集进一步研究。
要点
- 基于MRI的AI检测直肠癌淋巴结转移汇总敏感度0.71、特异度0.71、AUC 0.77。
- 放射科医生汇总敏感度0.64、特异度0.72、AUC 0.74,与AI诊断性能相似。
- 研究间存在高异质性,限制结论强度,需外部验证数据集确认。
核心结论
- 基于MRI的AI诊断性能与放射科医生相似。
- 研究间高异质性限制这些发现的强度,需外部验证数据集进一步研究以确认结果并评估实际临床价值。
研究设计与样本
- 研究类型为Meta分析,检索PubMed、Embase和Web of Science截至2024年9月发表的相关研究。
- 纳入17项评估基于MRI的AI检测直肠癌淋巴结转移诊断性能的研究。
- 采用双变量随机效应模型计算汇总敏感度和特异度及95%CI,用I²统计量评估研究间异质性,并用改良QUADAS-2工具评估方法学质量。
诊断标准与关键数值
- 基于MRI的AI检测直肠癌术前淋巴结转移的汇总敏感度为0.71(95%CI:0.66-0.74)。
- 基于MRI的AI检测直肠癌术前淋巴结转移的汇总特异度为0.71(95%CI:0.67-0.75)。
- 基于MRI的AI检测直肠癌术前淋巴结转移的汇总AUC为0.77(95%CI:0.73-0.80)。
- 放射科医生检测直肠癌淋巴结转移的汇总敏感度为0.64(95%CI:0.49-0.77)、特异度为0.72(95%CI:0.62-0.80)、AUC为0.74(95%CI:0.68-0.80)。
- AI与放射科医生两种分析均未显示显著发表偏倚(p > 0.05)。
临床应用与阅片要点
- 作者指出整合基于MRI的AI可提高识别淋巴结转移的诊断效率,尤其在缺乏熟练放射科医生的环境中,但需进一步验证。
局限性
- 研究间存在高异质性,限制这些发现的强度。
- 需外部验证数据集进一步研究以确认结果并评估实际临床价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This meta-analysis aims to evaluate the diagnostic performance of magnetic resonance imaging (MRI)-based artificial intelligence (AI) in the preoperative detection of lymph node metastasis (LNM) in patients with rectal cancer and to compare it with the diagnostic performance of radiologists.
METHODS: A thorough literature search was conducted across PubMed, Embase, and Web of Science to identify relevant studies published up to September 2024. The selected studies focused on the diagnostic performance of MRI-based AI in detecting rectal cancer LNM. A bivariate random-effects model was employed to calculate pooled sensitivity and specificity, each reported with 95% confidence intervals (CIs). Study heterogeneity was assessed using the I2 statistic. Furthermore, the modified quality assessment of diagnostic accuracy studies-2 (QUADAS-2) tool was applied to assess the methodological quality of the selected studies.
RESULTS: Seventeen studies were included in this meta-analysis. The pooled sensitivity, specificity, and area under the curve (AUC) for MRI-based AI in detecting preoperative LNM in rectal cancer were 0.71 (95% CI: 0.66-0.74), 0.71 (95% CI: 0.67-0.75), and 0.77 (95% CI: 0.73-0.80), respectively. For radiologists, these values were 0.64 (95% CI: 0.49-0.77), 0.72 (95% CI: 0.62-0.80), and 0.74 (95% CI: 0.68-0.80). Both analyses showed no significant publication bias (p > 0.05).
CONCLUSIONS: MRI-based AI demonstrates diagnostic performance similar to that of radiologists. The high heterogeneity among studies limits the strength of these findings, and further research with external validation datasets is necessary to confirm the results and assess their practical clinical value.
KEY POINTS: Question How effective is MRI-based AI in detecting LNM in rectal cancer patients compared to traditional radiology methods? Findings The diagnostic performance of MRI-based AI is comparable to radiologists, with pooled sensitivity and specificity both at 0.71, indicating moderate accuracy. Clinical relevance Integrating MRI-based AI can enhance diagnostic efficiency in identifying LNM, especially in settings with limited access to skilled radiologists, but requires further validation.
引用
- Bai Z, Xu L, Ding Z, et al. Artificial intelligence in magnetic resonance imaging for predicting lymph node metastasis in rectal cancer patients: a meta-analysis. Eur Radiol. 2025. PMID: 40220146. doi:10.1007/s00330-025-11519-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。